Point-of-care testing by healthcare workers for detection of meticillin-resistant Staphylococcus aureus, Clostridioides difficile, and norovirus.

A new interesting article has been published in J Hosp Infect. 2019 Dec; 103(4):447-453. doi: 10.1016/j.jhin.2019.08.002. Epub 2019 Aug 9. and titled:

Point-of-care testing by healthcare workers for detection of meticillin-resistant Staphylococcus aureus, Clostridioides difficile, and norovirus.

Authors of this article are:

Dewar S, Vass D, MacKenzie FM, Parcell BJ.

A summary of the article is shown below:

BACKGROUND: The feasibility of introducing three separate Cepheid GeneXpert® assays was assessed: Xpert SA Nasal Complete, Xpert C. difficile, and Xpert Norovirus for point-of-care testing (POCT) on a ward in a district general hospital.AIM: To establish a seven-day/24 h POCT service for meticillin-resistant Staphylococcus aureus (MRSA), Clostridioides difficile, and norovirus operated solely by healthcare workers (HCWs).METHODS: The Cepheid GeneXpert assays performance characteristics were assessed by comparing the assays to traditional central laboratory methods in terms of clinical turnaround times, hands-on time, number of process steps, time to result and diagnostic accuracy. HCW feedback was collected to consider the potential added value of applying this technology to improve patient flow and clinical care.FINDINGS: In total 1170 tests were carried out over the 16-month study period. The assays significantly reduced hands-on time, process steps, and time to result for identification of all three micro-organisms. Overall agreement with central laboratory testing was >98% for all three assays. Staff members fed back that POCT had a positive impact in terms of clinical utility.CONCLUSION: Xpert SA Nasal Complete for MRSA detection, Xpert C. difficile, and Xpert Norovirus can be used as POCT solely by HCWs in a ward setting. Each assay was used throughout a seven-day/24 h period with potential positive impact on bed management and patient care.Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/31404566 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: Cepheid; Clostridioides difficile; MRSA; Norovirus; POCT; Point-of-care.


NativeFolder: The Only Bacterial Culture Medium for the Expression of Soluble Proteins


Interference Test Kit for Assay Validation


Rheumatoid Factor Interference Blocker


New Antibodies from MOLECULAR DEPOT


New Proteins from MOLECULAR DEPOT


New Chemicals from MOLECULAR DEPOT

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.